Wednesday - September 30, 2026

Category Archives: Pharmaceuticals & Biotech

Everion Pharmaceuticals COO Announces 30% Company-Wide Promotion Across Expanded Research Portfolio

Newly appointed COO Alina Khomenko launches promotional initiative using code GET30OFF as Everion continues expanding its research pharmaceutical platform. Alina Khomenko, Chief Operating Officer, Everion Pharmaceuticals. Photo courtesy of Everion Pharmaceuticals. UNITED STATES – September 29, 2026 – Everion Pharmaceuticals today … Continue reading →

Sickle Cell Disease Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma

The Key Sickle Cell Disease Companies in the market include – BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharmaceuticals, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis Pharma, Editas Medicin, Pfizer, Emmaus Medical, Inc, Vertex Pharmaceuticals, CRISPR therapeutics, Bluebird Bio, Pfizer, Novo … Continue reading →

Chronic Wounds Pipeline 2026: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE

(Albany, New York) – September 29, 2026: As per DelveInsight’s assessment, globally, Chronic Wounds pipeline constitutes 3+ key companies continuously working towards developing 3+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Sjogren’s Syndrome Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherap

The Key Sjogren’s syndrome Companies in the market include – Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics, Bristol-Myers Squibb, Resolve Therapeutics, Novartis, Horizon Therapeutics, Dompe Farmaceutici, Horizon Therapeutics (Amgen), Sylentis, OSE Immunotherapeutics, Servier, Johnson & Johnson, and … Continue reading →

Metastatic Prostate Cancer Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Merck, Arvinas Androgen Receptor, UNICANCER, Aragon Pharma, Mark Stein

(Albany, New York) – September 29, 2026: The Key Metastatic Prostate Cancer Companies in the market include – Curium US LLC, Bayer, Hookipa Biotech GmbH, University Health Network, Merck Sharp & Dohme, Arvinas Androgen Receptor, UNICANCER, Aragon Pharmaceuticals, Mark Stein, … Continue reading →

Aplastic Anemia Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | Pfizer, Regeneron Pharma, Gamida-Cell, Kyowa Kirin, Novartis

(Albany, New York) – September 29, 2026: The Key Aplastic Anemia Companies in the market include – Teva Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Gamida-Cell, Kyowa Kirin, Novartis, Jiangsu HengRui Medicine Co., Ltd., Janssen Scientific Affairs, LLC, and others. DelveInsight’s “Aplastic Anemia … Continue reading →

Alcohol Use Disorder Market Outlook Shows Significant Expansion Across the 7MM Through 2036

Alcohol Use Disorder, or alcoholism, is a condition where excessive drinking affects physical health, thinking, and behavior, characterized by loss of control over alcohol use, inability to quit, cravings, increased tolerance, withdrawal symptoms, and neglect of responsibilities. New York, USA … Continue reading →

Actinic Keratosis Market Set to Witness Growth with Shorter-Duration Topical Therapies and Emerging Targeted Pipeline by 2036 – DelveInsight | Almirall, Biofrontera Pharma, Vidac Pharma

The Key Actinic Keratosis Companies in the market include – Almirall, Biofrontera Pharma GmbH, Vidac Pharma, Rubedo Life Sciences, and others. (Albany, US), September 29, 2026 – DelveInsight’s report “Actinic Keratosis Market Insights, Epidemiology, and Market Forecast – 2036” delivers … Continue reading →

Diabetic Foot Ulcers Market Set to Witness Growth with Advanced Regenerative Therapies and Evolving Pipeline by 2036 – DelveInsight | Integra Life Sciences, Lynch Regenerative Medicine, Smith & Nephew

The Key Diabetic Foot Ulcer Companies in the market include – Integra Life Sciences, Lynch Regenerative Medicine, Smith & Nephew, Rion, RHEACELL GmbH, FGK Clinical Research GmbH, Ticeba GmbH, Eluciderm, and others. (Albany, US), September 29, 2026 – DelveInsight’s report … Continue reading →

TNBC Clinical Trial Pipeline Gains Momentum: 165+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The TNBC Clinical Trials analysis report delivers important insights into ongoing research on 165+ pipeline TNBC Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 29, 2026- DelveInsight’s “Triple Negative Breast Cancer Pipeline Insight 2026” report provides comprehensive … Continue reading →